Protagonist Therapeutics (PTGX) PT Lowered to $41 at BTIG
Tweet
Share
E-mailGet Alerts PTGX Hot Sheet
Price: $155.10 +2.43%
Rating Summary:
20 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
20 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BTIG analyst Julian Harrison lowered the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $41.00 (from $45.00) while maintaining a Buy rating.
You May Also Be Interested In
- Protagonist Therapeutics (PTGX) PT Raised to $170 at Truist Securities
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
